AI Summary
This article highlights a study showing that adults who develop multiple sclerosis (MS) after the age of 50 are at a higher risk for rapid progression of the disease. The research indicates that late-onset MS is less likely to respond to disease-modifying therapy compared to MS developed at a younger age. These findings underscore the importance of early detection and intervention in MS cases, particularly in older adults.
MS that develops after age 50 tends to progress more rapidly than younger-onset MS and is less apt to respond to disease-modifying therapy, Swedish registry data show.
Medscape Medical News